GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of Sweden: external review, and what it actually costs here — 31 comments in the full submission. View in context.
601
c/insurancefights·submitted 11 months ago by u/wholesome_lurker

Sweden: external review, and what it actually costs here

Discussionbranch of 7 comments

Sweden: external review, and what it actually costs here, and I am aware this is a minority view on this board. The process that has actually worked for people on this board, in order. Get the denial in writing and find the criterion it names. Request the clinical policy bulletin by its number. Write the appeal…

Read the full submission and all 31 comments →

This branch

7 comments, started 10 months ago
u/formulary_fighterMOD53 points·10 months ago

Added a jurisdiction tag — the answers differ completely between countries and plan types.

replysharereportpermalink
u/wholesome_lurkerOP31 points·10 months ago·edited

Added a jurisdiction tag — the answers differ completely between countries and plan types.

Disagreeing with this line: the deadline runs from the letter date and treating it otherwise is expensive.

replysharereportpermalink
[removed]40 points·10 months ago

[removed by moderator]

replysharereportpermalink
u/tomas_lehtinen32 points·10 months ago

Which country and which plan year are we talking about?

replysharereportpermalink
u/ignacio_vanhecke0 points·10 months ago

Correction: that is a formulary exclusion, not a prior authorisation denial. Different form, different route, different deadline.

replysharereportpermalink
u/nadia_trevino9 points·10 months ago

Which country and which plan year are we talking about?

tomas_lehtinen is right that this is documentation rather than persuasion. It took me a year to accept that.

replysharereportpermalink
u/emeka_delgado22 points·10 months ago

Peer-to-peer took fifteen minutes and resolved something a written appeal had been sitting on for a month.

replysharereportpermalink

← back to the whole thread

About c/insurancefights

The paperwork war. Prior-authorisation criteria, denial reason codes, step-therapy documentation, external review, employer carve-outs, and the appeal letter templates the community has iterated on for three years. Mostly US-shaped but the tactics generalise.

46kmembers
95submissions
Dec 2023created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
c/insurancefights rules
  1. Say which country and which plan type. "Insurance" means eleven different things.
  2. Redact member ids and group numbers from every screenshot.
  3. Do not suggest misrepresenting a diagnosis. That is fraud and it gets you banned.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.